Endoproteolytic processing of the mammalian prion glycoprotein family

FEBS Journal

Volumn 281, Issue 3, 2014, Pages 862-876

  Mays, Charles E ^a   Coomaraswamy, Janaky ^b   Watts, Joel C ^c   Yang, Jing ^a   Ko, Kerry W S ^a   Strome, Bob ^c   Mercer, Robert C C ^a   Wohlgemuth, Serene L ^a   Schmitt Ulms, Gerold ^c   Westaway, David ^a,d  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Biogen Idec International GmbH   (Switzerland)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

ADAM; Doppel; Endoproteolysis; Prion protein; Shadoo

Indexed keywords

DOPPEL PROTEIN; PRION PROTEIN; SHADOO PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENDOPROTEOLYSIS; HYDROPHOBICITY; IN VIVO STUDY; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING;

ANIMALIA; MAMMALIAN PRION; SCRAPIE PRION;

ADAM; DOPPEL; ENDOPROTEOLYSIS; PRION PROTEIN; SHADOO;

ANIMALS; BRAIN; CELL LINE; ENDOPEPTIDASES; GLYCOPROTEINS; GLYCOSYLATION; GPI-LINKED PROTEINS; MALE; MICE; MICE, TRANSGENIC; MUTANT PROTEINS; NERVE TISSUE PROTEINS; NEURONS; PEPTIDE FRAGMENTS; PRIONS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; PROTEOLYSIS; PRPC PROTEINS; RABBITS; RECOMBINANT FUSION PROTEINS; TESTIS;

EID: 84897054936     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12654     Document Type: Article

References (76)

1. Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95, 13363-83.
2. Chen SG, Teplow D, Parchi P, Gambetti P & Autilio-Gambetti L (1995) Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem 270, 19173-80.
3. Jimenez-Huete A, Lievens PM, Vidal R, Piccardo P, Ghetti B, Tagliavini F, Frangione B & Prelli F (1998) Endogenous proteolytic cleavage of normal and diseaseassociated isoforms of the human prion protein in neural and non-neural tissues. Am J Pathol 153, 1561-72.
4. Mangé A, Béranger F, Peoc'h K, Onodera T, Frobert Y & Lehmann S (2004) Alpha-and beta-cleavages of the amino-terminus of the cellular prion protein. Biol Cell 96, 125-132.
5. Oliveira-Martins JB, Yusa S-I, Calella AM, Bridel C, Baumann F, Dametto P & Aguzzi A (2010) Unexpected tolerance of a-cleavage of the prion protein to sequence variations. PLoS ONE 5, e9107.
6. Flechsig E, Hegyi I, Leimeroth R, Zuniga A, Rossi D, Cozzio A, Schwarz P, Rulicke T, Gotz J, Aguzzi A et al. (2003) Expression of truncated PrP targeted to Purkinje cells of PrP knockout mice causes Purkinje cell death and ataxia. EMBO J 22, 3095-101.
7. Borchelt DR, Rogers M, Stahl N, Telling G & Prusiner SB (1993) Release of the cellular prion protein from cultured cells after loss of its glycoinositol phospholipid anchor. Glycobiology 3, 319-29.
8. Harris DA, Huber MT, van Dijken P, Shyng S-L, Chait BT & Wang R (1993) Processing of a cellular prion protein: identification of N-and C-terminal cleavage sites. Biochemistry 32, 1009-16.
9. Taylor DR, Parkin ET, Cocklin SL, Ault JR, Ashcroft AE, Turner AJ & Hooper NM (2009) Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein. J Biol Chem 284, 22590-600.
10. Tagliavini F, Prelli F, Porro M, Salmona M, Bugiani O & Frangione B (1992) A soluble form of prion protein in human cerebrospinal fluid: implications for prionrelated encephalopathies. Biochem Biophys Res Commun 184, 1398-404.
11. Endres K, Mitteregger G, Kojro E, Kretzschmar H & Fahrenholz F (2009) Influence of ADAM10 on prion protein processing and scrapie infectiosity in vivo. Neurobiol Dis 36, 233-41.
12. Altmeppen H, Prox J, Puig B, Kluth M, Bernreuther C, Thurm D, Jorissen E, Petrowitz B, Bartsch U, De Strooper B et al. (2011) Lack of a-disintegrin-andmetalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo. Mol Neurodegener 6, 36.
13. Moore R, Mastrangelo P, Bouzamondo E, Heinrich C, Legname G, Prusiner SB, Hood L, Westaway D, DeArmond S & Tremblay P (2001) Doppel-induced cerebellar degeneration in transgenic mice. Proc Natl Acad Sci USA 98, 15288-93.
14. Daude N, Wohlgemuth S, Brown R, Pitstick R, Gapeshina H, Yang J, Carlson GA & Westaway D (2012) Knockout of the prion protein (PrP)-like Sprn gene does not produce embryonic lethality in combination with PrPC-deficiency. Proc Natl Acad Sci USA 109, 9035-40.
15. Watts JC, Stöhr J, Bhardwaj S, Wille H, Oehler A, DeArmond SJ, Giles K & Prusiner SB (2011) Proteaseresistant prions selectively decrease shadoo protein. PLoS Pathog 7, e1002382.
16. Westaway D, Genovesi S, Daude N, Brown R, Lau A, Lee I, Mays CE, Coomaraswamy J, Canine B, Pitstick R et al. (2011) Down-regulation of shadoo in prion infections traces a pre-clinical event inversely related to PrPSc accumulation. PLoS Pathog 7, e1002391.
17. Watts JC, Drisaldi B, Ng V, Yang J, Strome B, Horne P, Sy MS, Yoong L, Young R, Mastrangelo P et al. (2007) The CNS glycoprotein Shadoo has PrP(C)-like protective properties and displays reduced levels in prion infections. EMBO J 26, 4038-50.
18. Silverman GL, Qin K, Moore RC, Yang Y, Mastrangelo P, Tremblay P, Prusiner SB, Cohen FE & Westaway D (2000) Doppel is an N-glycosylated, glycosylphosphatidylinositol-anchored protein. Expression in testis and ectopic production in the brains of Prnp0/0 mice predisposed to Purkinje cell loss. J Biol Chem 275, 26834-41.
19. Mo H, Moore RC, Cohen FE, Westaway D, Prusiner SB, Wright PE & Dyson HJ (2001) Two different neurodegenerative diseases caused by proteins with similar structures. Proc Natl Acad Sci USA 98, 2352-57.
20. Luhrs T, Riek R, Guntert P & Wuthrich K (2003) NMR structure of the human doppel protein. J Mol Biol 326, 1549-57.
21. Premzl M, Sangiorgio L, Strumbo B, Marshall Graves JA, Simonic T & Gready JE (2003) Shadoo, a new protein highly conserved from fish to mammals and with similarity to prion protein. Gene 314, 89-102.
22. Premzl M, Gready JE, Jermiin LS, Simonic T & Marshall Graves JA (2004) Evolution of vertebrate genes related to Prion and Shadoo proteins-clues from comparative genomic analysis. Mol Biol Evol 21, 2210-31.
23. Lau A, Mays CE, Genovesi S & Westaway D (2012) RGG repeats of PrP-like Shadoo protein bind nucleic acids. Biochemistry 51, 9029-31.
24. Gabus C, Derrington E, Leblanc P, Chnaiderman J, Dormont D, Swietnicki W, Morillas M, Surewicz WK, Marc D, Nandi P et al. (2001) The prion protein has RNA binding and chaperoning properties characteristic of nucleocapsid protein NCP7 of HIV-1. J Biol Chem 276, 19301-9.
25. Gabus C, Auxilien S, Péchoux C, Dormont D, Swietnicki W, Morillas M, Surewicz W, Nandi P & Darlix J-L (2001) The prion protein has DNA strand transfer properties similar to retroviral nucleocapsid protein. J Mol Biol 307, 1011-1021.
26. Macedo B, Millen TA, Braga CACA, Gomes MPB, Ferreira PS, Kraineva J, Winter R, Silva JL & Cordeiro Y (2012) Nonspecific prion protein-nucleic acid interactions lead to different aggregates and cytotoxic species. Biochemistry 51, 5402-13.
27. Miyazawa K & Manuelidis L (2010) Agent-specific Shadoo responses in transmissible encephalopathies. J Neuroimmune Pharmacol 5, 155-63.
28. Aguzzi A, Baumann F & Bremer J (2008) The prion's elusive reason for being. Annu Rev Neurosci 31, 439-77.
29. Linden R, Martins VR, Prado MAM, Cammarota M, Izquierdo I & Brentani RR (2008) Physiology of the prion protein. Physiol Rev 88, 673-728.
30. Biasini E, Turnbaugh JA, Unterberger U & Harris DA (2012) Prion protein at the crossroads of physiology and disease. Trends Neurosci 35, 92-103.
31. Liang J & Kong Q (2012) a-Cleavage of cellular prion protein. Prion 6, 453-60.
32. Altmeppen HC, Prox J, Puig B, Dohler F, Falker C, Krasemann S & Glatzel M (2013) Roles of endoproteolytic a-cleavage and shedding of the prion protein in neurodegeneration. FEBS J 280, 4338-47.
33. Sunyach C, Cisse MA, da Costa CA, Vincent B & Checler F (2007) The C-terminal products of cellular prion protein processing, C1 and C2, exert distinct influence on p53-dependent staurosporine-induced caspase-3 activation. J Biol Chem 282, 1956-63.
34. Westergard L, Turnbaugh JA & Harris DA (2011) A naturally occurring C-terminal fragment of the prion protein (PrP) delays disease and acts as a dominantnegative inhibitor of PrPSc formation. J Biol Chem 286, 44234-42.
35. Béland M & Roucou X (2012) The prion protein unstructured N-terminal region is a broad-spectrum molecular sensor with diverse and contrasting potential functions. J Neurochem 120, 853-68.
36. Guillot-Sestier MV, Sunyach C, Druon C, Scarzello S & Checler F (2009) The alpha-secretase-derived Nterminal product of cellular prion, N1, displays neuroprotective function in vitro and in vivo. J Biol Chem 284, 35973-86.
37. Guillot-Sestier M-V, Sunyach C, Ferreira ST, Marzolo M-P, Bauer C, Thevenet A & Checler F (2012) a-Secretase-derived fragment of cellular prion, N1, protects against monomeric and oligomeric amyloid b (Ab)-associated cell death. J Biol Chem 287, 5021-32.
38. Taraboulos A, Scott M, Semenov A, Avrahami D, Laszlo L & Prusiner SB (1995) Cholesterol depletion and targeting to clathrin coated pits inhibit formation of the scrapie prion protein. J Cell Biol 129, 121-32.
39. Shyng SL, Huber MT & Harris DA (1993) A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. J Biol Chem 268, 15922-28.
40. Walmsley AR, Watt NT, Taylor DR, Perera WSS & Hooper NM (2009) a-Cleavage of the prion protein occurs in a late compartment of the secretory pathway and is independent of lipid rafts. Mol Cell Neurosci 40, 242-48.
41. Sakudo A & Onodera T (2011) Tissue-and cell typespecific modification of prion protein (PrP)-like protein Doppel, which affects PrP endoproteolysis. Biochem Biophys Res Commun 404, 523-27.
42. Massimino ML, Ballarin C, Bertoli A, Casonato S, Genovesi S, Negro A & Sorgato MC (2004) Human Doppel and prion protein share common membrane microdomains and internalization pathways. Int J Biochem Cell Biol 36, 2016-31.
43. Daude N, Ng V, Watts JC, Genovesi S, Glaves JP, Wohlgemuth S, Schmitt-Ulms G, Young H, McLaurin J, Fraser PE et al. (2010) Wild-type Shadoo proteins convert to amyloid-like forms under native conditions. J Neurochem 113, 92-104.
44. Watts JC, Huo H, Bai Y, Ehsani S, Jeon AH, Shi T, Daude N, Lau A, Young R, Xu L et al. (2009) Interactome analyses identify ties of PrP and its mammalian paralogs to oligomannosidic N-glycans and endoplasmic reticulum-derived chaperones. PLoS Pathog 5, e1000608.
45. Ehsani S, Salehzadeh A, Huo H, Reginold W, Pocanschi CL, Ren H, Wang H, So K, Sato C, Mehrabian M et al. (2012) LIV-1 ZIP ectodomain shedding in prion-infected mice resembles cellular response to transition metal starvation. J Mol Biol 422, 556-574.
46. Sakthivelu V, Seidel RP, Winklhofer KF & Tatzelt J (2011) Conserved stress-protective activity between prion protein and shadoo. J Biol Chem 286, 8901-8.
47. Bëeler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, Prusiner SB, Aguet M & Weissmann C (1992) Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356, 577-82.
48. Behrens A, Genoud N, Naumann H, Rëlicke T, Janett F, Heppner FL, Ledermann B & Aguzzi A (2002) Absence of the prion protein homologue Doppel causes male sterility. EMBO J 21, 1-7.
49. Paisley D, Banks S, Selfridge J, McLennan NF, Ritchie AM, McEwan C, Irvine DS, Saunders PT, Manson JC & Melton DW (2004) Male infertility and DNA damage in Doppel knockout and prion protein/Doppel double-knockout mice. Am J Pathol 164, 2279-2288.
50. Genoud N, Behrens A, Miele G, Robay D, Heppner FL, Freigang S & Aguzzi A (2004) Disruption of Doppel prevents neurodegeneration in mice with extensive Prnp deletions. Proc Natl Acad Sci USA 101, 4198-203.
51. Liang J, Wang W, Sorensen D, Medina S, Ilchenko S, Kiselar J, Surewicz WK, Booth SA & Kong Q (2012) Cellular prion protein regulates its own a-cleavage through ADAM8 in skeletal muscle. J Biol Chem 287, 16510-20.
52. Moore R, Lee I, Silverman GS, Harrison P, Strome R, Heinrich C, Karunaratne A, Pasternak SH, Chishti MA, Liang Y et al. (1999) Ataxia in prion protein (PrP) deficient mice is associated with upregulation of the novel PrP-like protein doppel. J Mol Biol 293, 797-817.
53. Vilette D (2008) Cell models of prion infection. Vet Res 39, 10.
54. Peoc'h K, Guerin C, Brandel JP, Launay JM & Laplanche JL (2000) First report of polymorphisms in the prion-like protein gene (PRND): implications for human prion diseases. Neurosci Lett 286, 144-48.
55. Lu K, Wang W, Xie Z, Wong BS, Li R, Petersen RB, Sy MS & Chen SG (2000) Expression and structural characterization of the recombinant human doppel protein. Biochemistry 39, 13575-83.
56. Li Q, Chevalier C, Henry C, Richard C-A, Moudjou M & Vidic J (2013) Shadoo binds lipid membranes and undergoes aggregation and fibrillization. Biochem Biophys Res Commun 438, 519-25.
57. Petersen TN, Brunak S, von Heijne G & Nielsen H (2011) SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods 8, 785-786.
58. Sunyach C, Jen A, Deng J, Fitzgerald KT, Frobert Y, Grassi J, McCaffrey MW & Morris R (2003) The mechanism of internalization of glycosylphosphatidylinositol-anchored prion protein. EMBO J 22, 3591-601.
59. Daude N, Wohlgemuth S, Rogaeva E, Farid AH, Heaton M & Westaway D (2009) Frequent missense and insertion/deletion polymorphisms in the ovine Shadoo gene parallel species-specific variation in PrP. PLoS ONE 4, e6538.
60. Lutz J, Brabeck C, Niemann HH, Kloz U, Korth C, Lingappa VR & Bërkle A (2010) Microdeletions within the hydrophobic core region of cellular prion protein alter its topology and metabolism. Biochem Biophys Res Commun 393, 439-44.
61. Caputo A, Sarnataro D, Campana V, Costanzo M, Negro A, Sorgato MC & Zurzolo C (2010) Doppel and PrPC co-immunoprecipitate in detergent-resistant membrane domains of epithelial FRT cells. Biochem J 425, 341-51.
62. Priola SA & Lawson VA (2001) Glycosylation influences cross-species formation of protease-resistant prion protein. EMBO J 20, 6692-99.
63. Somerville RA (1999) Host and transmissible spongiform encephalopathy agent strain control glycosylation of PrP. J Gen Virol 80, 1865-72.
64. DeArmond SJ, Qiu Y, Sànchez H, Spilman PR, Ninchak-Casey A, Alonso D & Daggett V (1999) PrPC glycoform heterogeneity as a function of brain region: implications for selective targeting of neurons by prion strains. J Neuropathol Exp Neurol 58, 1000-9.
65. Xiao X, Yuan J, Haïk S, Cali I, Zhan Y, Moudjou M, Li B, Laplanche J-L, Laude H, Langeveld J et al. (2013) Glycoform-selective prion formation in sporadic and familial forms of prion disease. PLoS ONE 8, e58786.
66. Watt NT & Hooper NM (2005) Reactive oxygen species (ROS)-mediated beta-cleavage of the prion protein in the mechanism of the cellular response to oxidative stress. Biochem Soc Trans 33, 1123-25.
67. Walmsley AR, Zeng F & Hooper NM (2003) The N-terminal region of the prion protein ectodomain contains a lipid raft targeting determinant. J Biol Chem 278, 37241-48.
68. Sisodia SS (1992) b-Amyloid precursor protein cleavage by a membrane-bound protease. Proc Natl Acad Sci USA 89, 6075-79.
69. Pan KM, Stahl N & Prusiner SB (1992) Purification and properties of the cellular prion protein from Syrian hamster brain. Protein Sci 1, 1343-52.
70. Mays CE, Kim C, Haldiman T, Merwe JVD, Lau A, Yang J, Grams J, Bari MAD, Nonno R, Telling GC et al. (2014) Substrate reduction as a host response determining the tempo of prion disease. J Clin Invest in press.
71. Vincent B, Paitel E, Saftig P, Frobert Y, Hartmann D, De Strooper B, Grassi J, Lopez-Perez E & Checler F (2001) The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J Biol Chem 276, 37743-46.
72. Cisse MA, Sunyach C, Lefranc-Jullien S, Postina R, Vincent B & Checler F (2005) The disintegrin ADAM9 indirectly contributes to the physiological processing of cellular prion by modulating ADAM10 activity. J Biol Chem 280, 40624-31.
73. Béland M, Motard J, Barbarin A & Roucou X (2012) PrPC homodimerization stimulates the production of PrPC cleaved fragments PrPN1 and PrPC1. J Neurosci 32, 13255-63.
74. Wik L, Klingeborn M, Willander H & Linné T (2012) Separate mechanisms act concurrently to shed and release the prion protein from the cell. Prion 6, 498-509.
75. Drisaldi B, Coomaraswamy J, Mastrangelo P, Strome B, Yang J, Watts JC, Chishti MA, Marvi M, Windl O, Ahrens R et al. (2004) Genetic mapping of activity determinants within cellular prion proteins: N-terminal modules in PrPC offset pro-apoptotic activity of the doppel helix B/B' region. J Biol Chem 279, 55443-54.
76. Schneider CA, Rasband WS & Eliceiri KW (2012) NIH Image to Image J: 25 years of image analysis. Nat Methods 9, 671-75.